FDA Inspection 1231774 — Jubilant Generics Limited

Jubilant Generics Limited — FEI 3006895982

The FDA completed an inspection of Jubilant Generics Limited on February 2, 2024 in Bhagwanpur. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 2, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bhagwanpur (India)